Nano-X Imaging (NASDAQ:NNOX - Get Free Report)'s stock had its "buy" rating reaffirmed by stock analysts at D. Boral Capital in a research report issued on Friday,Benzinga reports. They currently have a $10.00 price target on the stock. D. Boral Capital's price target would suggest a potential upside of 81.16% from the company's previous close.
Several other research firms have also recently weighed in on NNOX. Cantor Fitzgerald lowered their price target on Nano-X Imaging from $12.00 to $9.00 and set an "overweight" rating on the stock in a report on Tuesday, April 1st. Alliance Global Partners restated a "buy" rating on shares of Nano-X Imaging in a research report on Thursday, May 22nd.
Check Out Our Latest Research Report on Nano-X Imaging
Nano-X Imaging Price Performance
NNOX stock traded down $0.01 during mid-day trading on Friday, hitting $5.52. 862,815 shares of the stock were exchanged, compared to its average volume of 1,750,801. The business has a fifty day moving average price of $5.04 and a 200 day moving average price of $6.28. Nano-X Imaging has a 12 month low of $3.75 and a 12 month high of $11.00. The stock has a market capitalization of $318.94 million, a price-to-earnings ratio of -6.49 and a beta of 1.99.
Nano-X Imaging (NASDAQ:NNOX - Get Free Report) last posted its earnings results on Thursday, May 22nd. The company reported ($0.21) EPS for the quarter, topping the consensus estimate of ($0.23) by $0.02. The firm had revenue of $3.00 million during the quarter, compared to analysts' expectations of $3.98 million. Nano-X Imaging had a negative net margin of 465.38% and a negative return on equity of 27.63%. As a group, equities analysts forecast that Nano-X Imaging will post -0.92 EPS for the current fiscal year.
Hedge Funds Weigh In On Nano-X Imaging
Institutional investors have recently modified their holdings of the stock. ARK Investment Management LLC boosted its holdings in Nano-X Imaging by 19.0% in the 4th quarter. ARK Investment Management LLC now owns 300,757 shares of the company's stock worth $2,165,000 after buying an additional 48,124 shares during the last quarter. Raymond James Financial Inc. purchased a new stake in Nano-X Imaging in the fourth quarter valued at approximately $251,000. Stifel Financial Corp increased its position in shares of Nano-X Imaging by 98.9% during the fourth quarter. Stifel Financial Corp now owns 23,318 shares of the company's stock worth $168,000 after acquiring an additional 11,596 shares during the period. Geode Capital Management LLC increased its position in shares of Nano-X Imaging by 1.6% during the fourth quarter. Geode Capital Management LLC now owns 688,512 shares of the company's stock worth $4,957,000 after acquiring an additional 10,659 shares during the period. Finally, Cetera Investment Advisers increased its position in shares of Nano-X Imaging by 132.2% during the fourth quarter. Cetera Investment Advisers now owns 32,441 shares of the company's stock worth $234,000 after acquiring an additional 18,469 shares during the period. Hedge funds and other institutional investors own 21.49% of the company's stock.
Nano-X Imaging Company Profile
(
Get Free Report)
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.
See Also
Before you consider Nano-X Imaging, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nano-X Imaging wasn't on the list.
While Nano-X Imaging currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.